Employees Provident Fund Board’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $111M | Buy |
|
|||||
|
2025
Q3 | $89.2M | Hold |
|
|||||
|
2025
Q2 | $91.6M | Buy |
|
|||||
|
2025
Q1 | $111M | Sell |
|
|||||
|
2024
Q4 | $162M | Sell |
|
|||||
|
2024
Q3 | $149M | Buy |
|
|||||
|
2024
Q2 | $103M | Buy |
|
|||||
|
2024
Q1 | $129M | Buy |
|
|||||
|
2023
Q4 | $89.7M | Buy |
|
|||||
|
2023
Q3 | $99.1M | Buy |
|
|||||
|
2023
Q1 | $8M | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $55.8M | Sell |
|
|||||
|
2022
Q1 | $61.1M | Sell |
|
|||||
|
2021
Q4 | $59.5M | Buy |
|
|||||
|
2021
Q3 | $52.4M | Hold |
|
|||||
|
2021
Q2 | $59.1M | Hold |
|
|||||
|
2021
Q1 | $55.9M | Hold |
|
|||||
|
2020
Q4 | $54.9M | Buy |
|
|||||
|
2020
Q3 | $40.7M | Buy |
|
|||||
|
2020
Q2 | $34M | Buy |
|
|||||
|
2020
Q1 | $20.7M | Sell |
|
|||||
|
2019
Q4 | $28.8M | Buy |
|
|||||
|
2019
Q3 | $1.57M | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $36.9M | Buy |
|